Genevant Sciences Corp.
Suite 155 – 877 Great Northern Way
Vancouver, BC V5T 4T5 Canada
Member Sector: Biopharmaceuticals
Genevant Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of a broad range of RNA-based therapeutics enabled by proprietary lipid nanoparticle (LNP) and ligand conjugate delivery technologies. Our industry- leading LNP platform has enabled clinical development of the most advanced RNA therapeutics with safety and efficacy evaluated in over 400 patients across multiple programs. We intend to discover and develop products to build a diverse pipeline of therapeutics across leading RNA modalities including RNAi, mRNA, and gene editing.